Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

8th MASH Drug Development Summit

24 September 2024 08:00 - 26 September 2024 16:15, Boston, MA, United States


Introduction
Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, AstraZeneca, Amgen, Akero Therapeutics and more that hold huge promise in Phase 1, 2, and 3 clinical trials. Paired with the boom of GLP-1s, these milestones have reinvigorated investment throughout the metabolic space.

The 8th MASH Drug Development Summit is the perfect forum to unite and discuss the evolving drug development opportunity for MASH and metabolic diseases. From optimizing clinical trial design to overcoming regulatory challenges, combatting fibrosis, navigating GLP-1 usage, optimizing RWE integration and achieving accurate non-invasive biomarkers, you won't find this industry-led insight anywhere else.

Join 120+ C-Level cardiometabolic stakeholders and thought leaders to make key connections, gain competitive insights and hear the latest data to shape the future of your MASH development pipeline.
Venue
Hilton Boston Logan Airport

Hilton Boston Logan Airport, One Hotel Drive, Boston, MA, 02128, United States

Contact information
Rhianna Price
Hanson Wade
+44 (0)20 3141 8700
Contact us by email

Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*